Search

Journal Multiple sclerosis

61. A novel in-home digital treatment to improve processing speed in people with multiple sclerosis: A pilot study. (April 2021)

Authors:
Bove, Riley; Rowles, William; Zhao, Chao; Anderson, Annika; Friedman, Samuel; Langdon, Dawn; Alexander, Amber; Sacco, Simone; Henry, Roland; Gazzaley, Adam; Feinstein, Anthony; Anguera, Joaquin A
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 5(2021)
Page Start:
778
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

62. A pharmacogenetic study implicates NINJ2 in the response to Interferon-β in multiple sclerosis. (August 2020)

Authors:
Peroni, Silvia; Sorosina, Melissa; Malhotra, Sunny; Clarelli, Ferdinando; Osiceanu, Ana Maria; Ferrè, Laura; Roostaei, Tina; Rio, Jordi; Midaglia, Luciana; Villar, Luisa María; Álvarez-Cermeño, José Carlos; Guaschino, Clara; Radaelli, Marta; Citterio, Lorena; Lechner-Scott, Jeannette; Spataro, Ni...
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 9(2020)
Page Start:
1074
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

63. A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis. (March 2021)

Authors:
Fox, Edward; Lovett-Racke, Amy E; Gormley, Matthew; Liu, Yue; Petracca, Maria; Cocozza, Sirio; Shubin, Richard; Wray, Sibyl; Weiss, Michael S; Bosco, Jenna A; Power, Sean A; Mok, Koby; Inglese, Matilde
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 3(2021)
Page Start:
420
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

64. A Phase 3, double-blind, placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment. (April 2022)

Authors:
Cohen, Jeffrey A; Cameron, Michelle H; Goldman, Myla D; Goodman, Andrew D; Miller, Aaron E; Rollins, Anne; Llorens, Lily; Patni, Rajiv; Elfont, Robert; Johnson, Reed
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 5(2022)
Page Start:
817
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

65. A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients. (June 2015)

Authors:
Derfuss, Tobias; Curtin, François; Guebelin, Claudia; Bridel, Claire; Rasenack, Maria; Matthey, Alain; Du Pasquier, Renaud; Schluep, Myriam; Desmeules, Jules; Lang, Alois B; Perron, Hervé; Faucard, Raphael; Porchet, Hervé; Hartung, Hans-Peter; Kappos, Ludwig; Lalive, Patrice H
Journal:
Multiple sclerosis
Issue:
Volume 21:Number 7(2015)
Page Start:
885
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

66. A pilot study of the effects of running training on visuospatial memory in MS: A stronger functional embedding of the hippocampus in the default-mode network?. (October 2020)

Authors:
Huiskamp, Marijn; Moumdjian, Lousin; van Asch, Paul; Popescu, Veronica; Schoonheim, Menno Michiel; Steenwijk, Martijn D; Vanzeir, Ellen; van Wijmeersch, Bart; Geurts, Jeroen JG; Feys, Peter; Hulst, Hanneke E
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 12(2020)
Page Start:
1594
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗